A detailed history of Northwest Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Bank & Trust CO holds 700 shares of ABBV stock, worth $142,485. This represents 0.11% of its overall portfolio holdings.

Number of Shares
700
Previous 700 -0.0%
Holding current value
$142,485
Previous $120 Million 15.14%
% of portfolio
0.11%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 23, 2024

SELL
$159.82 - $182.1 $13,744 - $15,660
-86 Reduced 10.94%
700 $114 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $104,152 - $129,611
786 New
786 $106 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwest Bank & Trust CO Portfolio

Follow Northwest Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bank & Trust CO with notifications on news.